Burning Rock Biotech (BNR) Change in Cash (2019 - 2026)

Burning Rock Biotech's Change in Cash history runs 8 years deep, the most recent figure standing at -$4.7 million for Q1 2026.

• In Q1 2026, Change in Cash fell 37.57% year-over-year to -$4.7 million; the TTM figure through Mar 2026 stood at -$10.4 million (up 53.42% YoY), while the FY2025 annual figure was -$5.9 million, up 53.93% from the prior year.
• Change in Cash for Q1 2026 stood at -$4.7 million, down from $2.0 million in the prior quarter.
• The five-year high for Change in Cash was $3.3 million in Q4 2024, with the low at -$74.5 million in Q4 2022.
• The 5-year median for Change in Cash is -$9.4 million (2025), against an average of -$13.0 million.
• The sharpest annual moves came in 2022 and 2024: Change in Cash tumbled 190.44% in 2022, then surged 208.04% in 2024.
• Burning Rock Biotech's Change in Cash stood at -$74.5 million in 2022, then jumped by 95.93% to -$3.0 million in 2023, then soared by 208.04% to $3.3 million in 2024, then tumbled by 38.42% to $2.0 million in 2025, then sank by 332.46% to -$4.7 million in 2026.
• Business Quant data shows BNR's Change in Cash at -$4.7 million in Q1 2026, $2.0 million in Q4 2025, and $1.7 million in Q3 2025.